SUBSCRIBERS
GIC affiliate, ADIA unit buy minority stake in US$9b pharma company
Published Thu, Apr 27, 2017 · 09:50 PM
Singapore
AN affiliate of Singapore's sovereign wealth fund GIC and a subsidiary of the Abu Dhabi Investment Authority (ADIA) have bought a minority stake in Pharmaceutical Product Development (PPD), valuing the pharmaceutical company at US$9.05 billion.
The stake in the United States-based contract research organisation (CRO) was bought from the affiliates of Hellman & Friedman and the affiliates of The Carlyle Group.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Sri Lanka’s economy expected to grow 3% in 2024, central bank says
Yellen says US can bring inflation down without hurting jobs
US dollar briefly falls versus yen after GDP data
US weekly jobless claims unexpectedly fall
US economic growth slows more than expected in Q1
Malaysia ex-PM Mahathir facing anti-graft probe in a case involving his sons